| First Author | Zhuang H | Year | 2016 |
| Journal | EMBO Mol Med | Volume | 8 |
| Issue | 8 | Pages | 895-918 |
| PubMed ID | 27357657 | Mgi Jnum | J:273986 |
| Mgi Id | MGI:6274194 | Doi | 10.15252/emmm.201505924 |
| Citation | Zhuang H, et al. (2016) FADD is a key regulator of lipid metabolism. EMBO Mol Med 8(8):895-918 |
| abstractText | FADD, a classical apoptotic signaling adaptor, was recently reported to have non-apoptotic functions. Here, we report the discovery that FADD regulates lipid metabolism. PPAR-alpha is a dietary lipid sensor, whose activation results in hypolipidemic effects. We show that FADD interacts with RIP140, which is a corepressor for PPAR-alpha, and FADD phosphorylation-mimic mutation (FADD-D) or FADD deficiency abolishes RIP140-mediated transcriptional repression, leading to the activation of PPAR-alpha. FADD-D-mutant mice exhibit significantly decreased adipose tissue mass and triglyceride accumulation. Also, they exhibit increased energy expenditure with enhanced fatty acid oxidation in adipocytes due to the activation of PPAR-alpha. Similar metabolic phenotypes, such as reduced fat formation, insulin resistance, and resistance to HFD-induced obesity, are shown in adipose-specific FADD knockout mice. Additionally, FADD-D mutation can reverse the severe genetic obesity phenotype of ob/ob mice, with elevated fatty acid oxidation and oxygen consumption in adipose tissue, improved insulin resistance, and decreased triglyceride storage. We conclude that FADD is a master regulator of glucose and fat metabolism with potential applications for treatment of insulin resistance and obesity. |
